Aligos Therapeutics, Inc. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
Aligos Therapeutics, Inc. (ALGS) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax of $1.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Investments › Debt and Equity Securities
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2021-11-04
- 2021-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $1.00K.
- 2021-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $1.00K.
- 2021-03-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $27.00K.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2021-09-30 | $1.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $27.00K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |